PLYMOUTH MEETING, Pa., June 25, 2018 /PRNewswire/ -- Braeburn announces that Richard Malamut, M.D. has joined the company as Chief Medical Officer. Dr. Malamut brings to Braeburn more than 25 years of ...
ALISO VIEJO, Calif., Nov. 29, 2016 /PRNewswire/ -- Avanir Pharmaceuticals, Inc. today announced that Richard Malamut, MD, has joined the company as senior vice president, research and development, and ...
MONTPELLIER, France--(BUSINESS WIRE)--Regulatory News: MedinCell (Paris:MEDCL): "After working as an active member of the Medical Advisory Board of MedinCell, I am delighted to be joining full time ...
SAN ANTONIO — As an abuse-deterrent version of hydrocodone extended-release (ER) moves closer to market, the company developing the product (Vantrela ER, Teva Pharmaceutical Industries) has released ...
“Clinical development will become a significant part of MedinCell’s expenses and will define the time to market of our products. Bringing on board Richard, with his wealth of knowledge in ...
Dr. Rick Malamut is an expert in regulatory processes and drug development He oversaw the early clinical strategy of mdc-IRM at Teva (2013-2016) He is a former member of MedinCell’s Medical Advisory ...
ALISO VIEJO, Calif., Nov. 29, 2016 /PRNewswire/ -- Avanir Pharmaceuticals, Inc. today announced that Richard Malamut, MD, has joined the company as senior vice president, research and development, and ...
"After working as an active member of the Medical Advisory Board of MedinCell, I am delighted to be joining full time the company as a CMO at a time when its first product is in the final stage of the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results